Physician profile
Arjun Kanuri
NPI 1578981957
$5,828.95
in general payments reported to CMS, 2019-2025
18 companies · $793 in 2025
The $793 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $36.40 · 2021: $1,293 · 2022: $1,584 · 2023: $1,478 · 2024: $392 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,663.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,172.15 | 2021-2022 | |
| Abbvie INC. | $922.92 | 2023-2025 | |
| Sientra, INC. | $914.18 | 2021-2022 | |
| Integra Lifesciences Corporation | $835.24 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $417.82 | 2021-2022 | |
| Medtronic, INC. | $381.39 | 2022-2023 | Endurant Iis |
| Baxter Healthcare | $305.69 | 2023-2024 | Artiss |
| Abbott Laboratories | $236.98 | 2019 | |
| Innovation Technologies INC | $183.74 | 2023 | Irrisept |
| Mentor Worldwide LLC | $141.05 | 2022-2023 | Mentor Cpx 2 Breast Tissue Expander |
| Tela Bio, INC. | $126.06 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Pacira Pharmaceuticals Incorporated | $41.38 | 2024-2025 | Exparel |
| Merz North America, INC. | $36.40 | 2020 | |
| Axogen | $35.28 | 2025 | |
| Ethicon US, LLC | $31.96 | 2025 | Vistaseal, Dermabond Prineo, Stratafix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocircuit Technologies INC | $17.73 | 2025 | Nerve Tape |
| Polarityte, INC. | $14.93 | 2019 | |
| Bard Peripheral Vascular, INC. | $14.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arjun Kanuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.